Clinical trials
Phase 2 Hypercholesterolemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
125 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 7 |
| 2006 | 8 |
| 2007 | 10 |
| 2008 | 9 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 12 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 107 |
| Terminated | 5 |
| Not yet recruiting | 5 |
| Recruiting | 3 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esperion Therapeutics, Inc. | 9 |
| Amgen | 5 |
| Kastle Therapeutics, LLC | 5 |
| NeuroBo Pharmaceuticals Inc. | 5 |
| Regeneron Pharmaceuticals | 5 |
| Sanofi | 5 |
| Merck Sharp & Dohme LLC | 4 |
| Micropharma Limited | 4 |
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| NewAmsterdam Pharma | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 125 |
| Dyslipidemias | 22 |
| Hyperlipidemias | 20 |
| Cardiovascular Diseases | 11 |
| Atherosclerosis | 8 |
| Hypertension | 8 |
| Lipid Metabolism Disorders | 7 |
| Hypertriglyceridemia | 6 |
| Metabolic Diseases | 6 |
| Obesity | 5 |
Trials
Showing 26 to 50 of 125. Each trial links to its page on Pharma Observatory.
25 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.